InsidersTradesSigma
Discover the complete record of transactions filed by Jörgen Dahlström, Director. Officer active across 2 companies, notably Prostatype Genomics AB. Aggregated, 1 reports have been logged. History available since 9 June 2025. The latest transaction was filed on 9 June 2025 (Purchase). Regulator: FIN-FSA. All data is openly available.
1 of 1 declaration
Jörgen Dahlström is a Board Member of Prostatype Genomics AB, where he participates in the governance and strategy of the company. His expertise in the biotechnology sector is valuable for the development of Prostatype.